Symbolbild · KI-generiert
Genix Pharmaceuticals Corporation
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
Genix Pharmaceuticals Corporation is a highly innovative Canadian ophthalmic drugs company. The Company focusses on the research, development, manufacture, licensing and sales of novel and innovative prescription and OTC ophthalmological products which meet the growing needs of consumers worldwide and especially the aging baby boomers. The Company has several products awaiting Health Canada approval.
Company description as published by the issuer via TMX Money.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| Genix Pharmaceuticals Corporation | GENX | TSXV | 654.673 USD |
| Vencanna Ventures Inc. | VENI | CSE | 648.681 USD |
| Mary Agrotechnologies Inc | MARY | CSE | 614.892 USD |
| Nevis Brands Inc. | NEVI | CSE | 702.404 USD |
| Entheon Biomedical Corp. | ENBI.X | CSE | 592.777 USD |
| Waverley Pharma Inc. | WAVE | TSXV | 577.425 USD |
| Vitality Products Inc. | VPI | TSXV | 738.022 USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.